However , the r eason for the "explosive gr owth" of other
Rheumatology sales teams at that point in time was due, in par t, to MALLINCKRODT r equesting that its r epr esentative pr omote the Acthar dr ug in an illegal, off-label manner . 35. Fr anks was clear that he would not engage in illegal activities to incr ease sales... Despite this, and being advised that employees wer e told by compliance to not to "put anything in wr iting" ... 37. "A similar push and ack nowledgement that to k eep his job, Fr anks essentially had to push in off-label ar eas..." 40. Fr anks is infor med and believes that ther e wer e illegal sales pr actices being committed in other r egions...
42. Fr anks was also awar e of other compliance r elated issues
at MALLINCKRODT, which Fr anks is infor med and believes and ther eon alleges that these issues include but ar e not limited to: potentially insur ance/ Medicar e fr aud r elated to the r efills as noted above, HIPAA violations wher e four or eight week pr escr iptions wer e pr ovided wher e ther e was no patient visit ... This was done to "game the system" and potentially commit insur ance/ Medicar e fr aud.)